Magnesium and melatonin nightly supplement for nighttime leg cramps and poor sleep
Official title: An Investigation Into the Effect of a Daily Magnesium and Melatonin Based Multi-Ingredient Dietary Supplement on Sleep Quality in Individuals With Self-Reported Nighttime Leg Cramps.
Run by StudySetGo · NCT07651514 · Data updated 2026-11-12
A nightly magnesium and melatonin supplement is being tested to see if it improves sleep quality in adults with nighttime leg cramps.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 75 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | StudySetGo Research network |
| Locations | 7 sites (Birmingham, Alabama and 6 other locations) |
| Status | Recruiting |
| Started | October 10, 2026 |
| Main results expected | September 10, 2027 |
| Study ends | September 10, 2027 |
| Registry record updated | November 2, 2026 |
| Trial ID | NCT07651514 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 40–75 with daytime sleep issues and nocturnal leg cramps (at least 4 episodes per two weeks) who are willing to wear an Oura Ring and use a smartphone app.
✕Probably not a fit
Participants not benefiting may have cramps and sleep quality unchanged or may not respond to magnesium and melatonin.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study tests a multi-ingredient supplement containing magnesium and melatonin versus placebo over 8 weeks. Participants are randomly assigned to take the product or a matching placebo nightly for 6 weeks and wear an Oura Ring to track sleep, with data collected via a smartphone app. All participation is remote, with home delivery of the supplement and wearable, and no required travel to a clinic. The study screens adults 40–75 with self-reported poor sleep quality and nocturnal leg cramps, and requires smartphone access and home Wi-Fi connectivity for app use. Primary outcomes focus on sleep quality and cramp frequency as measured by self-reports and wearable data.
Why it matters
Potential benefit: If successful, participants may experience improved sleep quality and fewer nocturnal leg cramps.
How similar studies have gone: Previous research has explored magnesium or melatonin separately for sleep and cramps, with mixed results; this study tests a combined approach in a remote, real-world setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 40-75 years * Self-reported poor sleep quality (PSQI \>5) at screening * Self-reported nocturnal leg cramp averaging ≥4 episodes per fortnight at screening * Capacity to understand and provide electronic informed consent * Willing to wear an Oura Ring wearable device continuously throughout the study period * Access to a smartphone/tablet with iOS 15 or higher and Android 9 or higher and willing to install and use the Oura and Trialflare applications * Be a resident of and permanently living in Florida with no planned travel across more than one time zone for at least 1 night during the study period Exclusion Criteria: * Current or recent (within 4 weeks of randomisation) use of melatonin, magnesium, or other supplements specifically taken for sleep or leg cramps or listed as an ingredient of the intervention supplement. * Current use of any prescription medication * Diagnosed sleep disorder (e.g. obstructive sleep apnoea, restless legs syndrome, insomnia disorder) * Known or suspected secondary cause of nocturnal leg cramps (e.g. peripheral vascular disease, neurological condition, renal impairment, thyroid disorder) * Any current or prior diagnosis of: * Cancer or malignancy of any kind (prior malignancy is not exclusionary if the participant is in confirmed remission and has completed all treatment) * Cardiovascular disease (e.g. hypertension, coronary artery disease, heart failure, arrhythmia, stroke, peripheral vascular disease) * Autoimmune disorder (e.g. rheumatoid arthritis, lupus, multiple sclerosis) * Gastrointestinal disorder (e.g. IBS, malabsorption syndromes) * Neurological disorder (e.g. epilepsy, Parkinson's disease, dementia) * Hepatic or renal impairment * Diabetes mellitus (type 1 or type 2) * Severe psychiatric disorder (e.g. schizophrenia, bipolar disorder) * Myasthenia Gravis * Known hypersensitivity or allergy to any ingredient in the active or placebo product * Rotating shift work or irregular sleep patterns * Current participation in another interventional clinical trial * Inability to comply with study procedures or remote visit schedule * Breastfeeding, pregnant, or planning to become pregnant during the study period
Where it's running
-
Remote participation (home-based, no site visits)
Birmingham, Alabama, United States Recruiting -
Remote participation (home-based, no site visits)
Little Rock, Arkansas, United States Recruiting -
Remote participation (home-based, no site visits)
Palm Beach Gardens, Florida, United States Recruiting -
Remote participation (home-based, no site visits)
Atlanta, Georgia, United States Recruiting -
Remote participation (home-based, no site visits)
Charlotte, North Carolina, United States Recruiting -
Remote participation (home-based, no site visits)
Charleston, South Carolina, United States Recruiting
Show 1 more location
-
Remote participation (home-based, no site visits)
Nashville, Tennessee, United States Recruiting
Study contacts
- Study coordinator: MISIT Study Team
- Email: misit@studysetgo.com
- Phone: +18886119860
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Bioresorbable Magnesium Screws for Ankle Syndesmotic Injuries: A First Look
This pilot study tests whether a bioresorbable magnesium screw can safely fix ankle syndesmotic injuries in adults with isolated injuries or small fracture patterns.
-
Overnight Temperature Regulation to Test Gut Health, Inflammation, and Circadian Rhythms
This study tests whether two weeks of using the Eight Sleep Pod at night can improve gut bacteria balance, lower inflammation, and strengthen daily temperature and blood pressure rhythms in postmenopausal women and age-matched men with poor sleep.
-
Sleep and arterial function in hypertensive patients with poor sleep quality
This trial tests whether using cognitive-behavioural therapy for insomnia can improve artery health and well-being in adults with high blood pressure and poor sleep.
-
Oral vs IV Magnesium for Emergence Delirium in Children after Adenotonsillectomy
This trial tests whether giving magnesium by mouth before surgery or by IV during surgery can reduce emergence delirium in children aged 4–7 undergoing adenotonsillectomy with sevoflurane anesthesia.
-
Melatonin versus pregabalin for pain and anxiety after spine surgery
This trial will test whether taking melatonin or pregabalin around the time of elective spine surgery reduces postoperative pain and anxiety in adults aged 21–60.
-
Pistachio snacking to improve metabolic flexibility in adults with overweight
We will try eating pistachios for a few days to see if it helps adults with overweight or obesity use energy better at rest, during exercise, and after exercise.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.